Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

U. of California reports new purine cyclin-dependent kinase inhibitors

March 30, 1999

NCI initiates pilot trial of thalidomide as adjunct in cancer therapy

March 30, 1999

Bioniche technology offers synergistic benefits in cancer therapy

March 29, 1999

Sugen's new protein tyrosine kinase inhibitors

March 26, 1999

Searle characterizes new vitronectin antagonist with antitumor activity at ACS meeting

March 25, 1999

MethylGene initiates phase I clinical trials of MG-98 for solid tumors

March 25, 1999

DuPont presents 4-aminoquinazoline cyclin-dependent kinase inhibitors

March 24, 1999

High-affinity RARalpha receptor agonists reported by Eisai at ACS meeting

March 24, 1999

NCI scientists evaluate MMP inhibitor from CollaGenex

March 23, 1999

ACS highlights: design of new antitumor agents based on computer models of tubulin structure

March 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....